Latest Research, Industry, Medical and Scientific News
Urolon, A New Treatment for Female Stress Urinary Incontinence, Launches in the UK
Stress Urinary Incontinence (SUI) is the most common type of urinary incontinence. According to estimations around 1 in 3 women will experience bladder leakage at some point in their life. SUI happens when the sphincter muscle that controls the urethra, the pelvic floor tissues and muscles that are used to keep the urethra closed, weakens. Urolon developed by Netherlands-based AQLANE Medical, is solving for this. Urolon is a bioresorbable, non-permanent filler that is completely removed from your body over time. The treatment is minimally invasive, takes around 20 minutes and can be performed in a hospital or clinic. Three small injections into the urethral wall restore its closure. Read more.
Source: FemTech Insider, October 6, 2022
What is Incontinence-Associated Dermatitis?
Incontinence-associated dermatitis (IAD) is a form of dermatitis caused by irritants that develop from chronic exposure to urine or liquid feces. Incontinence-associated dermatitis (MASD) consists of one of four types of moisture-associated skin damage. Moisture-associated skin damage has been defined as gradual inflammation and skin erosion resulting from prolonged exposure to several sources of moisture, including perspiration, wound exudate, mucus, saliva, urine, or feces. Read more.
Source: News-medical.net, September 28,2022
Why People with Diabetes Have More UTIs and How to Prevent Infections
Infections, especially urinary tract infections (UTIs), are common experiences for people with diabetes. UTIs are also often more severe in people with diabetes than they are in those without diabetes. UTIs may lead to serious kidney problems in those with diabetes, such as renal abscesses, emphysematous cystitis and pyelonephritis, and renal papillary necrosis. Read more.
Source: Medical News Today, September 27, 2022
Viveca Biomed Launches Contrelle To Create ‘Revolution’ In Tackling Stress Urinary Incontinence
Viveca Biomed has launched an innovative and clinically-proven bladder support device, Contrelle that offers women immediate relief from stress urinary incontinence (SUI) and provides community pharmacy contractors with a way to build a new consumer base, customer loyalty and sales margins. The product, named ‘Contrelle Activgard’, has already recorded millions of sales in Scandinavia over a decade. Read more.
Source: Pharmacy Business, August 24, 2022
NorthShore Care Supply Begins Clinical Trial to Re-Evaluate Protocols with Senior Care Facilities & Residents Managing Heavy Incontinence
NorthShore Care Supply’s first clinical trial begins in senior care facilities. The trial will test a new approach to incontinence care for residents. Since 2002, NorthShore has served over 2.5 million families in the United States. Several thousand 5-star customer reviews state that NorthShore products give adults more confidence and better sleep. Family caregivers also notice more sleep and fewer nighttime changes. Maintaining healthy skin is a top concern for individuals who wear adult diapers, and NorthShore delivers. Read more.
Source: Globe Newswire, August 6, 2022
Yoga App Eases in Incontinence in 4 Weeks
People with incontinence who used the Yoga of Immortals mobile app had significant improvement in the frequency and severity of urine leaks in four weeks, a new study shows. The globally used app combines specific yogic postures in the Sanatan tradition with breathing exercises, sound therapy, and meditation. Read more
Source: Futurity, July 27, 2022